| Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria |
21 |
| Risk factors for QTc interval prolongation |
16 |
| Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis |
16 |
| The nocebo effect challenges the non-medical infliximab switch in practice |
15 |
| Non-steroidal anti-inflammatory drugs and risk of Parkinson's disease in the elderly population: a meta-analysis |
15 |
| Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine |
12 |
| Safety, tolerability and pharmacokinetics of GSK300 a novel integrin alpha v beta 6 inhibitor, in healthy participants |
12 |
| Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature |
11 |
| Identifying potentially inappropriate prescribing in older people with dementia: a systematic review |
10 |
| Regulation of biosimilar medicines and current perspectives on interchangeability and policy |
10 |
| Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers |
10 |
| Categorization and association analysis of risk factors for adverse drug events |
9 |
| Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews |
9 |
| The associations of geriatric syndromes and other patient characteristics with the current and future use of potentially inappropriate medications in a large cohort study |
9 |
| Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis |
9 |
| Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children |
9 |
| Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden |
9 |
| A systematic review and novel classification of listing tools to improve medication in older people |
9 |
| Presentations to the emergency department with non-medical use of benzodiazepines and Z-drugs: profiling and relation to sales data |
8 |
| Medication errors in hospitals in the Middle East: a systematic review of prevalence, nature, severity and contributory factors |
8 |
| Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 65 an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases |
8 |
| A systematic literature review on strategies to avoid look-alike errors of labels |
8 |
| A comprehensive review and meta-analysis of risk factors for statin-induced myopathy |
8 |
| Association of DNA methylation in BDNF with escitalopram treatment response in depressed Chinese Han patients |
8 |
| Effect of itraconazole, food, and ethnic origin on the pharmacokinetics of ivosidenib in healthy subjects |
8 |
| Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study |
8 |
| Interaction potential of the dual orexin receptor antagonist ACT-541468 with CYP3A4 and food: results from two interaction studies |
8 |
| Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial |
7 |
| Chronic hypnotic use at 10yearsdoes the brand matter? |
7 |
| Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature |
7 |
| In vitro studies and in silico predictions of fluconazole and CYP2C9 genetic polymorphism impact on siponimod metabolism and pharmacokinetics |
7 |
| Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants |
7 |
| Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs |
7 |
| Measuring medication adherence in older community-dwelling patients with multimorbidity |
6 |
| Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling |
6 |
| Clinically relevant drug-drug interactions among elderly people with dementia |
6 |
| Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics |
6 |
| Feasibility of and patients' perspective on nilotinib dried blood spot self-sampling |
6 |
| N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians |
6 |
| Can screening tools for potentially inappropriate prescriptions in older adults prevent serious adverse drug events? |
6 |
| Half-dose ticagrelor versus high-dose clopidogrel in reducing platelet reactivity in acute coronary syndrome patients with high on-clopidogrel platelet reactivity (divide study) |
6 |
| Use of prescription drugs in the older adult population-a nationwide pharmacoepidemiological study |
6 |
| Dexmedetomidine as a sedative and analgesic adjuvant in spine surgery: a systematic review and meta-analysis of randomized controlled trials |
6 |
| Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder |
6 |
| Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis |
6 |
| Tailored P2Y(12) inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study |
6 |
| Medicine use and medicine-related problems in patients with liver cirrhosis: a systematic review of quantitative and qualitative studies |
5 |
| Medication and medical diagnosis as risk factors for falls in older hospitalized patients |
5 |
| The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects |
5 |
| Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review |
5 |
